BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1667960)

  • 21. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative electron microscopic studies on benign liver tumors and jaundice associated with contraceptive drugs].
    Balázs M
    Morphol Igazsagugyi Orv Sz; 1979 Jan; 19(1):1-9. PubMed ID: 431539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Liver pathology associated with anabolic androgenic steroids].
    Søe KL; Søe M; Gluud CN
    Ugeskr Laeger; 1994 Apr; 156(17):2585-8. PubMed ID: 8016966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Liver tumors in women using oral hormonal contraceptives].
    Rabe T; Feldmann K; Grunwald K; Runnebaum B
    Zentralbl Gynakol; 1995; 117(3):153-6. PubMed ID: 7740850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Contraceptives and the liver].
    Schmid M
    Leber Magen Darm; 1981 Sep; 11(5):216-26. PubMed ID: 7300550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicology and Carcinogenesis Studies of Furan (CAS No. 110-00-9) in F344 Rats and B6C3F1 Mice(Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Jan; 402():1-286. PubMed ID: 12621516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biology of hepatocellular neoplasia in the mouse. III. Electron microscopy of safrole-induced hepatocellular adenomas and hepatocellular carcinomas.
    Lipsky MM; Hinton DE; Klaunig JE; Trump BF
    J Natl Cancer Inst; 1981 Aug; 67(2):393-405. PubMed ID: 6943377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex hormones and risk of liver tumor.
    Giannitrapani L; Soresi M; La Spada E; Cervello M; D'Alessandro N; Montalto G
    Ann N Y Acad Sci; 2006 Nov; 1089():228-36. PubMed ID: 17261770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTP Toxicology and Carcinogenesis of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 384():1-348. PubMed ID: 12692652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple tumors after androgen therapy.
    Sale GE; Lerner KG
    Arch Pathol Lab Med; 1977 Nov; 101(11):600-3. PubMed ID: 199136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features.
    Kerlin P; Davis GL; McGill DB; Weiland LH; Adson MA; Sheedy PF
    Gastroenterology; 1983 May; 84(5 Pt 1):994-1002. PubMed ID: 6299876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver.
    Nakamura K; Zen Y; Sato Y; Kozaka K; Matsui O; Harada K; Nakanuma Y
    Hum Pathol; 2007 Oct; 38(10):1532-46. PubMed ID: 17640715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of well-differentiated hepatocellular carcinoma in large adenomatous hyperplasia after long-term follow-up: a case report.
    Midorikawa Y; Ishikawa T; Kubota K; Mori M; Takayama T; Makuuchi M
    Hepatogastroenterology; 2002; 49(46):1098-101. PubMed ID: 12143212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oral hormonal contraceptives and benign liver tumors].
    Giedl J; Gebhardt C
    Fortschr Med; 1981 Feb; 99(6):165-70. PubMed ID: 7274960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptives and benign tumors of the liver.
    Fitz JG
    West J Med; 1984 Feb; 140(2):260-7. PubMed ID: 6730471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Estrogen and progesterone receptors in human liver: does their study contribute to a better understanding of benign contraceptive-associated liver tumors?].
    Pirovino M; Wälti E; Akovbiantz A; Arrenbrecht S; Zava D; Bühler H; Schmid M
    Schweiz Med Wochenschr; 1986 Jul; 116(29):971-3. PubMed ID: 3020682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Association of hepatocellular adenoma and focal nodular hyperplasia of the liver in a woman on oral contraceptives].
    Defrance R; Zafrani ES; Hannoun S; Saada M; Fagniez PL; Métreau JM
    Gastroenterol Clin Biol; 1982 Nov; 6(11):949-50. PubMed ID: 6295869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.